ALBERT LABS INTL. CORP.
VB50 - F
Overview
Dividend safety
Dividends
Fundamentals
Add to watchlist
Add to calculator
Compare stock
ALBERT LABS INTL. CORP.
VB50
-F
Overview
Create a free account to get access to stock details and our dividend tracker
We won't send you any spam and we don't want a credit card.
About stock
Health care
Sector
Biotechnology
Industry
Albert Labs International Corp., a biopharmaceutical drug discovery company, researches and develops drugs for psychedelic-assisted therapy for patients with urgent and unmet needs in Canada and the United Kingdom. It develops KRN-101, is a solution for cancer-related anxiety. The company is based in Burnaby, Canada.
Similar stocks
Based on sector and market capitalization
Report issue